Morning cortisol increases hepatic glucose output and insulin demand.

The physiological peak of cortisol in the morning, often referred to as the cortisol awakening response, plays a critical role in metabolic regulation. Research confirms that elevated levels during this window directly stimulate hepatic glucose production and increase the subsequent demand for insulin to maintain glycemic stability.

Clinical and effectiveness evidence

Studies involving human subjects demonstrate that the elevation of cortisol significantly alters glucose kinetics.

• Hepatic Glucose Release: Mimicking the morning cortisol rise in clinical settings has been shown to increase hepatic glucose output (for instance, from approximately 1.5 to 2.6 nmol/kg/min).
• Insulin Suppression Shifts: Cortisol infusion studies indicate that it shifts the insulin dose-response curve to the right. To achieve the same level of glucose suppression as baseline, the body may require approximately 2.5 times more insulin when cortisol levels are elevated.
• Compensatory Hyperinsulinemia: Because cortisol drives glucose production while simultaneously impairing its disposal in peripheral tissues, pancreatic beta-cells must increase insulin secretion (compensatory hyperinsulinemia) to prevent hyperglycemia.

Mechanistic explanations

The metabolic impact of cortisol is driven by specific transcriptional and signaling pathways:

• Enzymatic Up-regulation: Cortisol binds to the Glucocorticoid Receptor (GR), which recruits coactivators like CRTC2 and CBP. This complex activates the promoters of key gluconeogenic enzymes, specifically Phosphoenolpyruvate carboxykinase (PEPCK) and Glucose-6-phosphatase (G6Pase).
• Antagonistic Signaling: While insulin typically inhibits PEPCK by disrupting RNA polymerase II recruitment, elevated cortisol can override this signal, promoting sustained glucose output despite the presence of insulin.
• Peripheral Impairment: Cortisol induces post-receptor defects in skeletal muscle and adipose tissue, often disrupting the PI3K/AKT signaling pathway and the translocation of the GLUT4 glucose transporter, further increasing the systemic insulin demand.

Bottom line

Strong clinical evidence supports the claim that morning cortisol increases hepatic glucose output via the transcriptional up-regulation of PEPCK and G6Pase. This process, combined with cortisol-induced peripheral insulin resistance, forces a compensatory increase in insulin demand to maintain euglycemia.